The efficacy and safety of meloxicam (Movalis®) in the treatment of rheumatic diseases

The efficacy and safety of meloxicam (Movalis®) in the treatment of rheumatic diseases

Saved in:

Bibliographic Details
Main Authors:	Tatyana Alekseyevna Raskina, M V Letayeva, O A Pirogova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2012-06-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/420
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01)

General medical aspects of the use of meloxicam (Movalis®) in clinical practice: Efficacy and safety
by: Natalia Vladimirovna Chichasova
Published: (2012-12-01)

New possibilities of movalis administration in rheumatic diseases
by: E. S. Tsvetkova, et al.
Published: (2003-08-01)

Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
by: O. N. Gerasimova, et al.
Published: (2011-12-01)

The Study of the Effectiveness of Meloxicam “Movalis” Application in Postoperative Patients with Planovalgus Foot Deformity
by: Yatskevych A., et al.
Published: (2016-12-01)

Neurological manifestations of systemic rheumatic diseases. Possibilities of pharmacological
by: T A Raskina, et al.
Published: (2011-12-01)

Prospects for using meloxicam in old-age group patients with rheumatic diseases
by: O N Egorova, et al.
Published: (2008-12-01)

The side effect profile of nonsteroidal anti-inflammatory drugs for rheumatic
by: T A Raskina, et al.
Published: (2011-12-01)

Meloxicam efficacy and safety in treatment of pain syndromes of different localization according to domestic studies
by: O. A. Shavlovskaya, et al.
Published: (2021-12-01)

Melox (meloxicam) clinical efficacy in chronic joint diseases
by: Sh Erdes, et al.
Published: (2003-08-01)

Aceclofenac: therapeutic effectiveness in osteoarthrosis
by: Tatyana Alekseyevna Raskina
Published: (2010-12-01)

Pentoxifylline in Dogs With Osteoarthritis: Comparative Treatment and Efficacy Analysis With Meloxicam
by: Kurtuluş Parlak, et al.
Published: (2025-07-01)

MELOXICAM: WHAT DO WE KNOW ABOUT CARDIOVASCULAR SAFETY?
by: M S Eliseev, et al.
Published: (2010-03-01)

GENDER PECULIARITIES OF THE OSTEOPENIC SYNDROME IN THE DEPENDENCE ON THE RHEUMATOID INFLAMMATION ACTIVITY
by: Tatyana Alekseyevna Raskina, et al.
Published: (2010-09-01)

EFFICACY AND SAFETY OF TOFACITINIB FOR IMMUNEMEDIATED INFLAMMATORY RHEUMATIC DISEASES (PART II)
by: E. L. Nasonov, et al.
Published: (2020-04-01)

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
by: E. L. Nasonov, et al.
Published: (2020-02-01)

Nimulid efficacy and tolerability in patients with rheumatic diseases
by: R M Balabanova, et al.
Published: (2004-02-01)

MELOXICAM: USE PROSPECTS IN ERYTHEMA NODOSUM
by: O N Egorova, et al.
Published: (2010-03-01)

Nonspecific pain in the lumbosacral area: clinical features of and approachesto drug therapy (according to the materials of the European guidelinesfor the management of nonspecific lumbosacral pain)
by: Tat'yana Alekseevna Raskina, et al.
Published: (2011-06-01)

Sulfasalazine efficacy and tolerability in rheumatic diseases
by: V. V. Badokin
Published: (2005-08-01)

Spectrophotometric determination of meloxicam in medicinal products
by: S. O. Vasyuk, et al.
Published: (2025-07-01)

BONE MINERAL DENSITY IN MALES WITH DIFFERENT CLINICAL TYPES OF RHEUMATOID ARTHRITIS
by: T A Raskina, et al.
Published: (2011-04-01)

MORTALITY IN PROXIMAL FEMUR FRACTURES IN AN OLD-AGE GROUP OF KEMEROVO AS A RATIONALE FOR THE NECESSITYOF MEDICAL PREVENTION OF OSTEOPOROSIS
by: Tat'yana Alekseevna Raskina, et al.
Published: (2011-03-01)

Iguratimod efficacy in palindromic rheumatism treatment
by: Fangfang Yuan, et al.
Published: (2023-06-01)

Efficacy, Immunogenicity, and Safety of the Combined Vector Vaccine Gam-COVID-Vac in Patients with Rheumatic Diseases
by: A. N. Kulikov, et al.
Published: (2024-11-01)

Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01)

Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01)

Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01)

What is safer for the gastrointestinal-tract: Coxibs or meloxicam?
by: A. M. Satybaldyev, et al.
Published: (2017-03-01)

ETHORICOXIB IN THE TREATMENT OF RHEUMATIC DISEASES
by: Yu A Olyunin, et al.
Published: (2010-03-01)

Efficacy and safety of the Gam-COVID-Vac in patients with immunoinflammatory rheumatic diseases: preliminary data of prospective study
by: A. N. Kulikov, et al.
Published: (2023-12-01)

Effect of Meloxicam and Nano-meloxicam on selected haematological and immunological parameters in arthritis-induced male albino rats
by: Adel Bashar, et al.
Published: (2025-06-01)

Prospects for using injectable meloxicam (Amelotex®) in patients with osteoarthrosis
by: M S Eliseyev, et al.
Published: (2009-03-01)

Assessment of efficacy of a new scheme of movalis administration in osteoarthritis and rheumatoid arthritis (data of a TOC \o "1-5" \h \z Russian multicentr study)
by: E S Tsvetkova
Published: (2005-04-01)

EVALUATION OF PROHYPERTENSIVE EFFECT OF MELOXICAM ON THE BLOOD PRESSURE INDICATORS
by: R. V. Nikiforov, et al.
Published: (2019-02-01)

Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases
by: Ramaswamy Subramanian, et al.
Published: (2019-01-01)

Cell technologies in the treatment of rheumatic diseases
by: N. F. Soroka, et al.
Published: (2019-12-01)

Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-09-01)

Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome
by: Jingjing Li, et al.
Published: (2025-06-01)

USE OF INJECTABLE MELOXICAM (AMELOTEX®) FORMULATION IN PATIENTS WITH GONARTHROSIS
by: M S Eliseyev, et al.
Published: (2009-09-01)